Angiostatin-mediated suppression of cancer metastases by primary neoplasms engineered to produce granulocyte/macrophage colony-stimulating factor

Journal of Experimental Medicine

Volumn 188, Issue 4, 1998, Pages 755-763

  Dong, Zhongyun ^a,b   Yoneda, Junya ^a   Kumar, Rakesh ^a   Fidler, Isaiah J ^a  

^a UNIVERSITY OF TEXAS   (United States)

^b UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

Angiogenesis; Angiostatin; Granulocyte macrophage colony stimulating factor; Metastasis; Tumor

Indexed keywords

ANGIOSTATIN; ELASTASE; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; MESSENGER RNA;

ANGIOGENESIS; ANIMAL CELL; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER INHIBITION; CARCINOGENICITY; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; IMMUNOBLOTTING; IMMUNOHISTOCHEMISTRY; MACROPHAGE; MALE; METASTASIS; MOUSE; NEOPLASM; NONHUMAN; NORTHERN BLOTTING; POLYACRYLAMIDE GEL ELECTROPHORESIS; PRIORITY JOURNAL;

ANGIOSTATINS; ANIMALS; ANTINEOPLASTIC AGENTS; CELLS, CULTURED; GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR; INJECTIONS, SUBCUTANEOUS; LUNG NEOPLASMS; MACROPHAGES; MALE; MELANOMA; MICE; MICE, INBRED C3H; MICE, INBRED C57BL; MICE, NUDE; PEPTIDE FRAGMENTS; PLASMINOGEN; TUMOR CELLS, CULTURED;

EID: 0032541472     PISSN: 00221007     EISSN: None     Source Type: Journal    
DOI: 10.1084/jem.188.4.755     Document Type: Article

References (41)

1. Folkman, J. 1995. Angiogenesis in cancer, vascular, rheumatoid and other disease. Nat. Med. 1:27-31.
2. Folkman, J. 1995. Clinical application of research on angiogenesis. N. Engl. J. Med. 333:1753-1763.
3. Auerbach, W., and R. Auerbach. 1994. Angiogenesis inhibition: a review. Pharmacol. Ther. 63:265-311.
4. Folkman, J., and M. Klagsburn. 1987. Angiogenic factors. Science. 235:444-447.
5. Cockerill, G.W., J.R. Gamble, and M.A. Vadas. 1995. Angiogenesis: models and modulators. Int. Rev. Cytol. 159: 113-160.
6. Hanahan, D., and J. Folkman. 1996. Patterns and emerging mechanisms of the angiogenic switch during tumorigenesis. Cell. 86:353-364.
7. Fidler, I.J., and L.M. Ellis. 1994. The implications of angiogenesis to the biology and therapy of cancer metastasis. Cell. 79:185-188.
8. O'Reilly, M.S., L. Holmgren, Y. Shing, C. Chen, R.A. Rosenthal, M. Moses, W.S. Lane, Y. Cao, E.H. Sage, and J. Folkman. 1994. Angiostatin: a novel angiogenesis inhibitor that mediates the suppression of metastases by a Lewis lung carcinoma. Cell. 79:315-328.
9. O'Reilly, M.S., L. Holmgren, C. Chen, and J. Folkman. 1996. Angiostatin induces and sustains dormancy of human primary tumors in mice. Nat. Med. 2:689-692.
10. Dong, Z., R. Kumar, X. Yang, and I.J. Fidler. 1997. Macrophage-derived metalloelastase is responsible for the generation of angiostatin in Lewis lung carcinoma. Cell. 88:801-810.
11. Gately, S., P. Twardowski, M.S. Stack, M. Patrick, L. Boggio, D.L. Cundiff, H.W. Schnaper, L. Madison, O. Volpert, N. Bouck, et al. 1996. Human prostate carcinoma cells express enzymatic activity that converts human plasminogen to the angiogenesis inhibitor, angiostatin. Cancer Res. 56:4887-4890.
12. Gately, S., P. Twardowski, M.S. Stack, D.L. Cundiff, D. Grella, F.J. Castellino, J. Enghild, H.C. Kwaan, F. Lee, R.A. Kramer, et al. 1997. The mechanism of cancer-mediated conversion of plasminogen to the angiogenesis inhibitor angiostatin. Proc. Natl. Acad. Sci. USA. 94:10868-10872.
13. Patterson, B.C., and Q.A. Sang. 1997. Angiostatin-converting enzyme activities of human matrilysin (MMP-7) and gelatinase B/type IV collagenase (MMP-9). J. Biol. Chem. 272: 28823-28825.
14. Kumar, R., Z. Dong, and I.J. Fidler. 1996. Differential regulation of metalloelastase activity in murine peritoneal macrophages by granulocyte-macrophage colony-stimulating factor and macrophage colony-stimulating factor. J. Immunol. 157:5104-5111.
15. Raz, A., W.E. Fogler, and I.J. Fidler. 1979. The effects of experimental conditions on expression of in vitro mediated tumor cytotoxicity by murine macrophages. Cancer Immunol. Immunother. 7:157-163.
16. Staroselsky, A.H., S. Pathak, Y. Chernajovsky, S.L. Tucker, and I.J. Fidler. 1991. Predominance of the metastatic phenotype in somatic cell hybrids of the K-1735 murine melanoma. Cancer Res. 51:6292-6298.
17. Killion, J.J., P.J. Beltran, C.A. O'Brian, S.-S. Yoon, D. Fan, M.R. Wilson, and I.J. Fidler. 1995. The antitumor activity of doxorubicin against drug-resistant murine carcinoma is enhanced by oral administration of a synthetic staurosporine analogue, CGP 41251. Oncol. Res. 7:453-459.
18. Dinney, C.P.N., C.D. Bucana, T. Utsugi, I.J. Fidler, A.C. von Eschenbach, and J.J. Killion. 1991. Therapy of spontaneous lung metastasis of murine renal adenocarcinoma by systemic administration of liposomes containing the macrophage activator CGP 31362. Cancer Res. 51:3741-3747.
19. Dong, Z., X. Qi, K. Xie, and I.J. Fidler. 1993. Protein tyrosine kinase inhibitors decrease induction of nitric oxide synthase activity in lipopolysaccharide-responsive and lipopolysaccharide-nonresponsive murine macrophages. J. Immunol. 151:2717-2724.
20. Werb, Z., M.J. Banda, J.H. McKerrow, and R.A. Sandhaus. 1982. Elastases and elastin degradation. J. Invest. Dermatol. 79: 154S-159S.
21. Dong, Z., R. Radinsky, D. Fan, R. Tsan, C.D. Bucana, C. Wilmanns, and I.J. Fidler. 1994. Organ-specific modulation of steady-state mdr gene expression and drug resistance in murine colon cancer cells. J. Natl. Cancer Inst. 86:913-920.
22. Fort, P., L. Marty, M. Liechaczyk, S.E. Sabrouty, C. Dani, and J.M. Blanchard. 1985. Various rat adult tissues express only one major mRNA species from the glyceraldehyde-3-phosphate-dehydrogenase multigenic family. Nucleic Acids Res. 13:1431-1442.
23. Shapiro, S.D., G.L. Griffin, D.J. Gilbert, N.A. Jenkins, N.G. Copeland, H.G. Welgus, R.M. Senior, and T.J. Ley. 1992. Molecular cloning, chromosomal localization, and bacterial expression of a murine macrophage metalloelastase. J. Biol. Chem. 267:4664-4671.
24. Dong, Z., X. Qi, and I.J. Fidler. 1993. Tyrosine phosphorylation of mitogen-activated protein kinases is necessary for activation of murine macrophages by natural and synthetic bacterial products. J. Exp. Med. 177:1071-1077.
25. Hughes, D.A., I.P. Fraser, and S. Gordon. 1994. Murine M phi scavenger receptor: adhesion function and expression. Immunol. Lett. 43:7-14.
26. Ju, D.W., X. Cao, and B. Acres. 1996. Active specific immunotherapy of pulmonary metastasis with vaccinia melanoma oncolysate prepared from granulocyte/macrophage-colony-stimulating-factor-gene-encoded vaccinia virus. J. Cancer Res. Clin. Oncol. 122:716-722.
27. Qin, H., and S.K. Chatterjee. 1996. Cancer gene therapy using tumor cells infected with recombinant vaccinia virus expressing GM-CSF. Hum. Gene Ther. 7:1853-1860.
28. Prehn, R.T. 1991. The inhibition of tumor growth by tumor mass. Cancer Res. 51:2-4.
29. Prehn, R.T. 1993. Two competing influences that may explain concomitant tumor resistance. Cancer Res. 53:3266-3269.
30. Fish, B., N. Gunduz, J. Coyle, C. Ruddock, and E. Saffer. 1989. Presence of a growth-stimulating factor in serum following primary tumor removal in mice. Cancer Res. 49:1996-2001.
31. Gorelik, E. 1983. Concomitant tumor immunity and the resistance to a second tumor challenge. Adv. Cancer Res. 39: 71-120.
32. Gorelik, E. 1983. Resistance of tumor-bearing mice to a second tumor challenge. Cancer Res. 43:138-145.
33. Sugarbaker, E.V., J. Thornthwaite, and A.S. Ketcham. 1977. Inhibitory effect of a primary tumor on metastasis. In Progress in Cancer Research and Therapy, S.B. Day, W.P.L. Myers, P. Stansly, S. Garrattini, and M.G. Lewis, editors. Raven Press, Ltd., New York. 227-240.
34. Tyzzer, E.E. 1913. Factors in the production and growth of tumor metastases. J. Med. Res. 28:309-333.
35. Folkman, J. 1971. Tumor angiogenesis: therapeutic implications. N. Engl. J. Med. 285:1182-1186.
36. Folkman, J., and R. Cotran. 1976. Relation of vascular proliferation to tumor growth. Int. Rev. Exp. Pathol. 16:207-248.
37. Dvorak, H.F. 1986. Tumors: wounds that do not heal. Similarities between tumor stroma generation and wound healing. N. Engl. J. Med. 315:1650-1659.
38. Wu, Z., M.S. O'Reilly, J. Folkman, and Y. Shing. 1997. Suppression of tumor growth with recombinant murine angiostatin. Biochem. Biophys. Res. Commun. 236:651-654.
39. Sim, B.K., M.S. O'Reilly, H. Liang, A.H. Fortier, W. He, J.W. Madsen, R. Lapcevick, and C.A. Nacy. 1997. A recombinant human angiostatin protein inhibits experimental primary and metastatic cancer. Cancer Res. 57:1329-1334.
40. O'Reilly, M.S., L. Holmgren, C. Chen, and J. Folkman. 1996. Angiostatin induces and sustains dormancy of human primary tumors in mice. Nat. Med. 2:689-692.
41. Boehm, T., J. Folkman, T. Browder, and M.S. O'Reilly. 1997. Antiangiogenic therapy of experimental cancer does not induce acquired drug resistance. Nature. 390:404-407.